One paralyzed Bulgarian citizen can now walk again after revolutionary treatment in Poland, and contributed to a British scientist this achievement as' more impressive than the man walk on the moon. "
Darek Fidyk was paralyzed below the chest after being injured during a knife attack in 2010. Now he can walk on the basis of the frame, because the spinal cord activity was restored, transplant them into the glial cells in the nose, said the study, published Tuesday in the journal Cell Transplantation.
"When (the spinal cord) does not work, do not feel nearly half of its body. You feel helpless, lost, - the patient, who is now undergoing treatment in Wroclaw admitted to the Department, located in the center of Akron, said the British national broadcaster BBC program Panorama.
"When it starts to recover, you feel as if your life started again, as if you were born a second time. Feeling incredible, harder to describe, "- he added.
During this therapy have been taken within the olfactory system of specialized cells surrounding ol factorial (OGL), which was used as the cell tracks leading to the gradual regeneration of the adjacent nerve fibers in the spinal cord.
Wroclaw University neurosurgeon consultant Pawel Tabakow led the team of surgeons, have eliminated one of the patient's olfactory bulbs grown for crop OGL cells and transplant it into the back of the brain.
Scientists believe that the cells are embedded in the spinal cord above the injury site and below it, helped nerve cells to re-connect.
"Basically, we found the principle that nerve fibers can regrow and restore their function, if they provide the bridge" - University College London, explained Nero regeneration Geoff Raismanas Department Head, a British researcher who led the team in the overall project.
"For me, this is more impressive than the man walk on the moon. I believe that this is the moment when the paralysis becomes treatable, "- he added.
"It's amazing to see how the regeneration of the spinal cord, for many years it was considered impossible to become a reality," - said Mr. Tabakow.
Now the researchers plan to conduct clinical trials with ten other patients in Britain and Poland.
